Life Sciences
4.1
Study reveals hidden costs and risks in newborn hearing screening programs
Researchers have identified critical flaws in how health systems evaluate the financial returns of newborn hearing screening, showing that standard cost-effectiveness models often miss real-world expenses and fail to account for implementation challenges. The findings could reshape how policymakers decide which screening programs deserve funding and how much they're actually willing to spend.
Originaltitel: Modelling the cost-effectiveness of a newborn hearing screening programme; usability and pitfalls